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Background: Maternal infections during pregnancy, particularly with rubella virus,
were reported to increase the risk of diabetes in children. Widespread vaccination
has decreased the number of infants with congenital rubella syndrome in the United
States, although it remains a problem in developing countries. Because vaccine hesi-
tancy has recently increased, we investigated the association between congenital
infections with subsequent diabetes risk in children in the United States.
Methods: Using data from a nationwide private health insurer for years 2001-2017,
1 475 587 infants were followed for an average of 3.9 years (maximum 16.5 years).
Information was obtained regarding congenital infections (rubella, cytomegalovirus,
other congenital infections) and perinatal infections, as well as for the development
of diabetes mellitus and diabetic ketoacidosis.
Results: There were 781 infants with congenital infections and 73 974 with perinatal
infections. Diabetes developed in 3334 children. The odds of developing diabetes
for infants with congenital rubella infection were 12-fold greater (P = .013) and, for
infants with congenital cytomegalovirus infection, were 4-fold greater (P = .011) than
infants without congenital or perinatal infection. Infants with other congenital infec-
tions had 3-fold greater odds of developing diabetes (P = .044). Results were similar
for diabetes ketoacidosis. Infants with other perinatal infections had 49% greater
odds of developing diabetes during the follow-up period (P < .001).
Conclusion: Congenital and other perinatal infections are associated with elevated
risks of developing diabetes mellitus during childhood. Vaccination for rubella remains
an important preventive action to reduce the incidence of diabetes in children.
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1 | INTRODUCTION
Prior to widespread vaccination, maternal infections during preg-
nancy, particularly with rubella virus, were reported to increase the
risk of diabetes in children.1 Long-term observation of individuals with
congenital rubella syndrome demonstrated that approximately 22%
developed diabetes by 60 years of age.2 In a cohort study of children
from New York, 12.4% of the 242 children with congenital rubella
Received: 9 November 2019 Accepted: 2 December 2019
DOI: 10.1111/pedi.12957
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
456 Pediatric Diabetes. 2020;21:456–459.wileyonlinelibrary.com/journal/pedi
syndrome developed diabetes by 17 years of age.3 Given a back-
ground rate of approximately 22 incident cases of diabetes per
100 000 children per year in the United States,4 one child would have
been expected to develop type 1 diabetes by age 17 in the New York
cohort, instead of the 30 cases that actually occurred.3 The elevated
rate of diabetes in children born with congenital rubella syndrome
was often noted by physicians over the past half century.2
Congenital rubella infection remains an important public health
issue in many countries and vaccination efforts to prevent rubella are
ongoing.5 Not all congenital infections, however, can be prevented
through vaccination and, with increased world travel, exposures during
pregnancy remain a concern.6 Congenital cytomegalovirus infection, for
example, occurs in both developed and developing countries and there
is currently no vaccine, although vaccine development efforts are
underway.7 Because vaccine hesitancy has increased over the past
20 years in the United States—particularly for the measles, mumps,
rubella (MMR) vaccine,8 we investigated associations between infec-
tion, both congenital and perinatal, with subsequent diabetes risk in a
longitudinal study in the United States between 2001 and 2017.
2 | METHODS
Data were from a nationwide private health insurer in the United
States (Clinformatics DataMart Database, years 2001–2017). All
infants with a minimum of 1 year of continuous insurance coverage
were included, with the sole exclusion of infants with neonatal diabe-
tes. Information was extracted regarding congenital rubella (ICD-
9771.0 or ICD-10 P35.0), congenital cytomegalovirus (ICD-9771.1 or
ICD-10 P35.1), other congenital infections (ICD-9771.2 or ICD-10
P35.2, P37.0, P37.1, P37.3, P37.4, P37.8; listed as congenital herpes
simplex, listeriosis, malaria, toxoplasmosis, or tuberculosis), and other
perinatal infections (ICD-9771.3 to ICD-9771.8 or ICD-10 P35.2 to
ICD-10 P35.9). Other perinatal infections were defined as acquired
either in utero, during birth via the umbilicus, or during the first
28 days after birth. For purposes of this study and given the con-
straints of the ICD coding, we will refer to “other perinatal infections”
as those infections acquired either in utero, during birth via the umbi-
licus, or during the first 28 days after birth—but excluding the congen-
ital infections as categorized above (rubella, cytomegalovirus, herpes
simplex, listeriosis, malaria, toxoplasmosis, tuberculosis). Because con-
genital rubella infection has been associated with both type 1 and
type 2 diabetes,2,9 diabetes was determined using ICD-9 codes 249.x
or 250.x, or ICD-10 codes E08.x or E10.x or E11.x. Diabetic
ketoacidosis was identified by ICD-9 codes 250.1x, 250.3x and ICD-
10 codes E10.1x, E11.1x, and E13.1x. In sensitivity analyses, the sam-
ple was restricted to type 1 diabetes, using only ICD-9250.x1 or 250.
x3, or ICD-10 E10.x. Logistic regression was performed to assess the
association between congenital infections and diabetes, with Stata/
MP 14.2 (StataCorp LLC, College Station, Texas). Two-sided P-values
less than .05 were considered significant. This study was approved by
the University of Michigan Institutional Review Board. Publicly
available de-identified data were used and informed consent was not
required.
3 | RESULTS
There were 1 475 587 infants who had insurance coverage for a mini-
mum of 365 days (maximum 16.5 years). Infants were observed for a
mean of 3.9 years (SD = 2.9). Of the infants, 48.6% were girls and
51.4% were boys.
There were 781 infants (0.06%) who had congenital infections
and 73 974 (5.01%) who had other perinatal infections. There were
38 infants with congenital rubella infection, 316 with congenital cyto-
megalovirus infection, and 427 infants with other congenital infec-
tions. During follow-up, diabetes occurred in 3334 children,
242 (0.33%) who had a perinatal infection and seven (0.90%) with
congenital infections (one with rubella, three with cytomegalovirus,
and three with other congenital infections), compared to 3085
(0.22%) without congenital/perinatal infection (P < .001).
In a logit model, the odds of developing diabetes for infants with
congenital rubella infection were 12-fold greater than those without
(Table 1). Infants with congenital cytomegalovirus infection also had
elevated odds of developing diabetes (odds ratio [OR] = 4.34). Other
congenital infections and other perinatal infections were also associ-
ated with diabetes mellitus (OR = 3.21 and 1.50, respectively). The
risk difference (attributable risk) for congenital rubella syndrome was
24 per 1000 births in this study. The median time from birth to diabe-
tes diagnosis for infants with perinatal infections (congenital and other
perinatal infections combined) was 1.6 years and for infants without
was 3 years.
There was also an association between diabetic ketoacidosis in
children and a prior history of congenital rubella infection
(OR = 12.41), congenital cytomegalovirus infection (OR = 4.40), other
congenital infections (OR = 3.25), as well as other perinatal infections
(OR = 1.50).
Because rotavirus vaccination during infancy has been shown to
lower rates of diabetes in childhood,10,11 the results were adjusted for
completion of the rotavirus vaccine series (Table 1). After adjustment,
congenital infections and other perinatal infections remained signifi-
cantly associated with the incidence of diabetes. Of note, of the
38 infants with congenital rubella syndrome, six completed the rotavi-
rus vaccine series and none developed diabetes. In the 32 infants with
congenital rubella syndrome who did not complete the rotavirus vac-
cine series, one developed diabetes. Of the 316 infants with congeni-
tal cytomegalovirus infection, 92 completed the rotavirus vaccine
series (none developed diabetes) and 224 did not complete the rotavi-
rus vaccine series (three developed diabetes).
In sensitivity analysis, the OR for congenital rubella infection and
type 1 diabetes was 23.53 (95% CI: 3.23, 171.62; P = .002). For con-
genital cytomegalovirus infection and type 1 diabetes, the OR was
8.35 (95% CI: 2.67, 26.04); P < .001). For other congenital infections,
the OR was 2.04 (95% CI: 0.29, 14.55; P = .475). For other perinatal
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infections and type 1 diabetes, the OR was 1.39 (95% CI: 1.15,
1.68; P = .001).
The frequency of congenital and perinatal infections (combined)
varied significantly (P < .001) across the country, from 7.0% in
New York and Pennsylvania to 3.1% on the Pacific coast (Figure 1).
4 | DISCUSSION
Congenital infections increase the risk of diabetes in the offspring.
Congenital rubella infection was rare but associated with risk, as was
cytomegalovirus infection. Perinatal infections, in general, were
associated with diabetes and diabetic ketoacidosis in children in this
study. Unfortunately, specific types of perinatal infections were only
available for certain types of etiologic agents in this database. From
previous research, various viruses have been implicated as triggers of
islet autoimmunity and the onset of diabetes in children.12 In a sys-
tematic review of maternal viral infections in pregnancy, a meta-
analysis of five case-control studies indicated a 2-fold increase in the
risk of type 1 diabetes in the offspring when infected with enterovirus
during pregnancy.13 To our knowledge, our study is the first cohort
study to report the association between congenital viral infections
and type 1 diabetes in children. Our findings affirm the previous
research regarding the association between congenital rubella
TABLE 1 Congenital and perinatal infections as predictors of diabetes mellitus in children, United States, 2001-2017
Category Number Unadjusted odds ratio 95% CI P-value Adjusted odds ratioa 95% CI P-value
Predictors of diabetes
Congenital rubella infection 38 12.25 1.68, 89.28 .013 11.23 1.54, 81.92 .017
Congenital cytomegalovirus infection 316 4.34 1.39, 13.55 .011 4.23 1.36, 13.21 .013
Other congenital infections 427 3.21 1.03, 9.98 .044 3.33 1.07, 10.37 .038
Other perinatal infections 73 974 1.49 1.30, 1.70 <.001 1.47 1.28, 1.68 <.001
No congenital or perinatal infections 1 400 832 1.00 Reference 1.00 Reference
Predictors of diabetic ketoacidosis
Congenital rubella infection 38 12.41 1.70, 90.51 .013 11.36 1.56, 82.89 .017
Congenital cytomegalovirus infection 316 4.40 1.41, 13.73 .011 4.29 1.38, 13.39 .012
Other congenital infections 427 3.25 1.04, 10.12 .042 3.38 1.08, 10.52 .036
Other perinatal infections 73 974 1.50 1.32, 1.71 <.001 1.48 1.29, 1.69 <.001
No congenital or perinatal infections 1 400 832 1.00 Reference 1.00 Reference
aAdjustment for completion of the rotavirus vaccine series during infancy.
F IGURE 1 Percentage of infants with
congenital and perinatal infections by
location, United States, 2001-2017.
†Middle Atlantic: Maryland, District of
Columbia, Virginia, West Virginia, North
Carolina, South Carolina. Southeast:
Florida, Georgia, Alabama, Mississippi,
Tennessee. North Central: Wisconsin,
Minnesota, Iowa, North Dakota, South
Dakota, Montana. Mountain: Idaho,
Wyoming, Colorado, Utah, Nevada, New
Mexico, Arizona. Pacific: California,
Oregon, Washington, Alaska, Hawaii
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infection and type 1 diabetes, but also suggest that congenital cyto-
megalovirus infection and other perinatal infections could also
influence risk.
Because live attenuated vaccines are contraindicated for pregnant
women, our findings emphasize the importance of completing the
rubella vaccine series at age-appropriate times to reduce the likeli-
hood of transmission from the general public to pregnant women.
Moreover, our results indicate that, among children with congenital
infections, completion of the rotavirus vaccine series may be a prag-
matic option to lower their risk of developing type 1 diabetes.
Screening for gestational diabetes and screening for type 2 diabe-
tes in adults is currently recommended, but there is insufficient evi-
dence for childhood diabetes screening in high risk groups.14,15 Our
results suggest that screening in populations at high risk of diabetes,
such as those with congenital rubella syndrome, should be evaluated.
For children with a history of congenital infection, parental education
regarding the symptoms of diabetic ketoacidosis is important. Diabe-
tes ketoacidosis, common in children when first diagnosed, can be
lethal and often results in hospitalization.16
In the United States, it is difficult to capture the total burden of
congenital and perinatal infections because national surveillance is
disease-specific, not all viral infections are under surveillance, and
reporting criteria have changed over time. In our study, we found that
perinatal infections (either in utero, during birth via the umbilicus, or
during the first 28 days after birth) tended to occur more frequently
in the eastern United States and ranged from 3.1% to 7.0% of live
births. As more large national databases become available, it is possi-
ble that additional information will be reported.
In conclusion, congenital and other perinatal infections are associ-
ated with the onset of diabetes mellitus in children. For some infections
such as rubella, vaccination is available and,17 therefore, the benefits of
vaccination should be emphasized in the population as a whole. Recog-
nition of the early symptoms of type 1 diabetes is important for parents
and guardians of children with a history of congenital infection.
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